Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine HCl Dose-ranging in Seasonal Allergic Rhinitis
NCT01330017Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2011
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of phenylephrine in seasonal allergic rhinitis (SAR) (5 arms), sponsored by Bayer. Primary endpoint: Mean Change From Baseline Over the Entire Treatment Period in the Daily Reflective Nasal Congestion Score at Day 7. Started Mar 2011; status: completed.
02
Drugs
phenylephrine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01330017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01330017.